The expression variation landscape of IRRGs and prognostic analysis of inflammatory response score
(A) Differential expression analysis of IRRGs between AML samples and normal samples, Wilcoxon test, *P<0.05; **P<0.01; ***P<0.001. (B) Prognosis-associated DEGs in IRRGs, Cox regression analysis. (C) The mutation characteristic of IRRGs in 134 AML patients from TCGA cohort. (D) Differences in the overall survival (OS) of patients in the high- and low-inflammatory response-score groups, log-rank test. (E) Differential expression analysis of pro-and anti-inflammatory genes between low- and high-inflammatory response groups.